|
Whiteside, Theresa L; Ferris, Robert L; Szczepanski, Miroslaw et al. (2016) Dendritic cell-based autologous tumor vaccines for head and neck squamous cell carcinoma. Head Neck 38 Suppl 1:E494-501
|
|
Visus, Carmen; Ito, Diasuke; Dhir, Rajiv et al. (2011) Identification of Hydroxysteroid (17?) dehydrogenase type 12 (HSD17B12) as a CD8+ T-cell-defined human tumor antigen of human carcinomas. Cancer Immunol Immunother 60:919-29
|
|
Hoffmann, Thomas K; Trellakis, Sokratis; Okulicz, Kornelia et al. (2011) Cyclin B1 expression and p53 status in squamous cell carcinomas of the head and neck. Anticancer Res 31:3151-7
|
|
Visus, Carmen; Wang, Yangyang; Lozano-Leon, Antonio et al. (2011) Targeting ALDH(bright) human carcinoma-initiating cells with ALDH1A1-specific CD8? T cells. Clin Cancer Res 17:6174-84
|
|
Czystowska, Malgorzata; Strauss, Laura; Bergmann, Christoph et al. (2010) Reciprocal granzyme/perforin-mediated death of human regulatory and responder T cells is regulated by interleukin-2 (IL-2). J Mol Med (Berl) 88:577-88
|
|
Macatangay, Bernard J C; Szajnik, Marta E; Whiteside, Theresa L et al. (2010) Regulatory T cell suppression of Gag-specific CD8 T cell polyfunctional response after therapeutic vaccination of HIV-1-infected patients on ART. PLoS One 5:e9852
|
|
Mandapathil, Magis; Hilldorfer, Benedict; Szczepanski, Miroslaw J et al. (2010) Generation and accumulation of immunosuppressive adenosine by human CD4+CD25highFOXP3+ regulatory T cells. J Biol Chem 285:7176-86
|
|
Andrade Filho, Pedro A; Ito, Daisuke; Deleo, Albert B et al. (2010) CD8+ T cell recognition of polymorphic wild-type sequence p53(65-73) peptides in squamous cell carcinoma of the head and neck. Cancer Immunol Immunother 59:1561-8
|
|
Albers, Andreas E; Schaefer, Carsten; Visus, Carmen et al. (2009) Spontaneous apoptosis of tumor-specific tetramer+ CD8+ T lymphocytes in the peripheral circulation of patients with head and neck cancer. Head Neck 31:773-81
|
|
Chikamatsu, Kazuaki; Sakakura, Koichi; Takahashi, Goro et al. (2009) CD4+ T cell responses to HLA-DP5-restricted wild-type sequence p53 peptides in patients with head and neck cancer. Cancer Immunol Immunother 58:1441-8
|
Showing the most recent 10 out of 94 publications
